Followers | 840 |
Posts | 120585 |
Boards Moderated | 14 |
Alias Born | 09/05/2002 |
Tuesday, January 14, 2020 5:14:15 PM
https://finance.yahoo.com/news/head-head-phase-3-data-134500909.html
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ABBV News
- U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease • PR Newswire (US) • 10/17/2024 12:00:00 PM
- Allergan Aesthetics to Present New Data at 2024 American Society for Dermatologic Surgery (ASDS) to Showcase Depth Across Facial Aesthetics and Insight into Patient Perception • PR Newswire (US) • 10/16/2024 12:00:00 PM
- Allergan Aesthetics and Girls Inc. Celebrate Six Years and Challenge You to Take the Pledge to Support Mentorship in STEM • PR Newswire (US) • 10/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:07:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 09:00:11 PM
- Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • InvestorsHub NewsWire • 10/02/2024 01:00:00 PM
- Available Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing • PR Newswire (US) • 10/02/2024 12:00:00 PM
- AbbVie to Host Third-Quarter 2024 Earnings Conference Call • PR Newswire (US) • 10/01/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 09:06:50 PM
- AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer • PR Newswire (US) • 09/27/2024 04:13:00 PM
- AbbVie et SpinUp encouragent l'innovation dans le secteur des sciences de la vie au Canada avec le lancement du Prix AbbVie des innovateurs en biotechnologies • PR Newswire (Canada) • 09/26/2024 12:00:00 PM
- AbbVie and SpinUp Foster Canadian Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award • PR Newswire (Canada) • 09/26/2024 12:00:00 PM
- AbbVie Announces Positive Topline Results from Phase 3 TEMPO-1 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease • PR Newswire (US) • 09/26/2024 12:00:00 PM
- New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement • PR Newswire (US) • 09/25/2024 11:00:00 AM
- Empowering Women Entrepreneurs: 2024 BOTOX® (onabotulinumtoxinA) Cosmetic Grant Recipients Kick Off Crowdfunding Campaigns • PR Newswire (US) • 09/24/2024 12:00:00 PM
- AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine (ELAHERE®) for the Treatment of Certain Adult Ovarian Cancer • PR Newswire (US) • 09/20/2024 11:32:00 AM
- Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China • PR Newswire (US) • 09/11/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 07:30:45 PM
- AbbVie reçoit l'approbation de Santé Canada pour l'emploi de CONSTELLA® (linaclotide) dans le traitement de la constipation fonctionnelle chez les enfants âgés de 6 à 17 ans • PR Newswire (Canada) • 09/10/2024 11:00:00 AM
- Health Canada Approves AbbVie's CONSTELLA® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients 6 to 17 Years of Age • PR Newswire (Canada) • 09/10/2024 11:00:00 AM
- AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High Unmet Needs • PR Newswire (US) • 09/09/2024 01:00:00 PM
- AbbVie Declares Quarterly Dividend • PR Newswire (US) • 09/06/2024 02:13:00 PM
- AbbVie's VRAYLAR® (cariprazine) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for the Treatment of Schizophrenia • PR Newswire (Canada) • 09/04/2024 12:00:00 PM
- AbbVie reçoit une recommandation favorable de la part de l'Agence des médicaments du Canada pour le remboursement de VRAYLAR® (cariprazine) dans le traitement de la schizophrénie • PR Newswire (Canada) • 09/04/2024 12:00:00 PM
- AbbVie Awards Scholarships to 45 U.S. Students Living With Chronic Immune-Mediated Diseases • PR Newswire (US) • 08/27/2024 12:15:00 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM